Publication | Open Access

Dasatinib, a small molecule inhibitor of the Src kinase, reduces the growth and activates apoptosis in pre-neoplastic Barrett's esophagus cell lines: Evidence for a noninvasive treatment of high-grade dysplasia

Src KinaseEsophagus Cell LinesHigh-grade DysplasiaEsophageal CancerMedicinePathologyCancer TreatmentOncologyCell BiologyCancer ResearchLung CancerTumor BiologyCancer Growth